ID

29291

Description

Omega-3 Fatty Acid Administration in Dialysis Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00655525

Link

https://clinicaltrials.gov/show/NCT00655525

Keywords

Versions (1)
  1. 3/16/18 3/16/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

March 16, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility End Stage Renal Disease NCT00655525

English

Eligibility End Stage Renal Disease NCT00655525

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients on chd for more than 6 months;
Description

Coronary heart disease Disease length

Data type

boolean

Alias
UMLS CUI [1,1]
C0010068
UMLS CUI [1,2]
C0872146
ability to read and sign the consent form;
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
have acceptable dialysis adequacy (kt/v > 1.2);
Description

Kt/V (peritoneal dialysis adequacy index)

Data type

boolean

Alias
UMLS CUI [1]
C3841650
use biocompatible hemodialysis membrane;
Description

Hemodialysis membrane Biocompatible materials

Data type

boolean

Alias
UMLS CUI [1,1]
C4047366
UMLS CUI [1,2]
C0005479
have a patent, well functioning, arteriovenous dialysis access or permanent dialysis catheter (no other option for arteriovenous access);
Description

Dialysis access Arteriovenous Patent | Dialysis catheter Permanent

Data type

boolean

Alias
UMLS CUI [1,1]
C3483464
UMLS CUI [1,2]
C0450109
UMLS CUI [1,3]
C0175566
UMLS CUI [2,1]
C0179747
UMLS CUI [2,2]
C0205355
signs of chronic inflammation (average crp of ≥ 5 mg/l for 3 consecutive measurements)
Description

Signs Chronic inflammation | C-reactive protein measurement Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0311392
UMLS CUI [1,2]
C0021376
UMLS CUI [2,1]
C0201657
UMLS CUI [2,2]
C1265611
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy;
Description

Pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0032961
intolerance to the study medication;
Description

Intolerance to Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0013230
severe, unstable, active, or chronic inflammatory disease (active infection, active connective tissue disorder, active cancer, hiv, liver disease);
Description

Inflammatory disorder Severe | Inflammatory disorder Unstable | Inflammatory disorder | Chronic inflammatory disorder | Communicable Disease | Connective Tissue Diseases | Malignant Neoplasms | HIV Infection | Liver disease

Data type

boolean

Alias
UMLS CUI [1,1]
C1290884
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C1290884
UMLS CUI [2,2]
C0443343
UMLS CUI [3]
C1290884
UMLS CUI [4]
C1290886
UMLS CUI [5]
C0009450
UMLS CUI [6]
C0009782
UMLS CUI [7]
C0006826
UMLS CUI [8]
C0019693
UMLS CUI [9]
C0023895
diabetes mellitus on insulin therapy;
Description

Insulin regime Diabetes Mellitus

Data type

boolean

Alias
UMLS CUI [1,1]
C0557978
UMLS CUI [1,2]
C0011849
hospitalization within 1 month prior to the study;
Description

Hospitalization

Data type

boolean

Alias
UMLS CUI [1]
C0019993
malfunctioning arterial-venous vascular access (recirculation and/or blood flow < 500 ml/min);
Description

Malfunction Vascular access Arteriovenous | Blood flow measurement

Data type

boolean

Alias
UMLS CUI [1,1]
C0231174
UMLS CUI [1,2]
C0750138
UMLS CUI [1,3]
C0450109
UMLS CUI [2]
C0005776
patients receiving steroids (> 5 mg/day) and/or other immunosuppressive agents;
Description

Steroids U/day | Immunosuppressive Agents

Data type

boolean

Alias
UMLS CUI [1,1]
C0038317
UMLS CUI [1,2]
C0456683
UMLS CUI [2]
C0021081
life-expectancy less than 6 months;
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
age less than 18 years old;
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
atrial fibrillation (only for those undergoing the optional pulse wave velocity);
Description

Atrial Fibrillation | Relationship Pulse Wave Velocity

Data type

boolean

Alias
UMLS CUI [1]
C0004238
UMLS CUI [2,1]
C0439849
UMLS CUI [2,2]
C3494431
hypersensitivity to organic nitrates, isosorbide, or nitroglycerin (only for those undergoing the optional brachial artery doppler).
Description

Hypersensitivity Nitrates organic | Hypersensitivity Isosorbide | Hypersensitivity Nitroglycerin | Relationship Doppler blood flow measurement Brachial artery

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0028125
UMLS CUI [1,3]
C0747055
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0022251
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0017887
UMLS CUI [4,1]
C0439849
UMLS CUI [4,2]
C0599582
UMLS CUI [4,3]
C0006087
Back to the top of the page

Similar models

Eligibility End Stage Renal Disease NCT00655525

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Coronary heart disease Disease length
Item
patients on chd for more than 6 months;
boolean
C0010068 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Informed Consent
Item
ability to read and sign the consent form;
boolean
C0021430 (UMLS CUI [1])
Kt/V (peritoneal dialysis adequacy index)
Item
have acceptable dialysis adequacy (kt/v > 1.2);
boolean
C3841650 (UMLS CUI [1])
Hemodialysis membrane Biocompatible materials
Item
use biocompatible hemodialysis membrane;
boolean
C4047366 (UMLS CUI [1,1])
C0005479 (UMLS CUI [1,2])
Dialysis access Arteriovenous Patent | Dialysis catheter Permanent
Item
have a patent, well functioning, arteriovenous dialysis access or permanent dialysis catheter (no other option for arteriovenous access);
boolean
C3483464 (UMLS CUI [1,1])
C0450109 (UMLS CUI [1,2])
C0175566 (UMLS CUI [1,3])
C0179747 (UMLS CUI [2,1])
C0205355 (UMLS CUI [2,2])
Signs Chronic inflammation | C-reactive protein measurement Quantity
Item
signs of chronic inflammation (average crp of ≥ 5 mg/l for 3 consecutive measurements)
boolean
C0311392 (UMLS CUI [1,1])
C0021376 (UMLS CUI [1,2])
C0201657 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Pregnancy
Item
pregnancy;
boolean
C0032961 (UMLS CUI [1])
Intolerance to Investigational New Drugs
Item
intolerance to the study medication;
boolean
C1744706 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Inflammatory disorder Severe | Inflammatory disorder Unstable | Inflammatory disorder | Chronic inflammatory disorder | Communicable Disease | Connective Tissue Diseases | Malignant Neoplasms | HIV Infection | Liver disease
Item
severe, unstable, active, or chronic inflammatory disease (active infection, active connective tissue disorder, active cancer, hiv, liver disease);
boolean
C1290884 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C1290884 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C1290884 (UMLS CUI [3])
C1290886 (UMLS CUI [4])
C0009450 (UMLS CUI [5])
C0009782 (UMLS CUI [6])
C0006826 (UMLS CUI [7])
C0019693 (UMLS CUI [8])
C0023895 (UMLS CUI [9])
Insulin regime Diabetes Mellitus
Item
diabetes mellitus on insulin therapy;
boolean
C0557978 (UMLS CUI [1,1])
C0011849 (UMLS CUI [1,2])
Hospitalization
Item
hospitalization within 1 month prior to the study;
boolean
C0019993 (UMLS CUI [1])
Malfunction Vascular access Arteriovenous | Blood flow measurement
Item
malfunctioning arterial-venous vascular access (recirculation and/or blood flow < 500 ml/min);
boolean
C0231174 (UMLS CUI [1,1])
C0750138 (UMLS CUI [1,2])
C0450109 (UMLS CUI [1,3])
C0005776 (UMLS CUI [2])
Steroids U/day | Immunosuppressive Agents
Item
patients receiving steroids (> 5 mg/day) and/or other immunosuppressive agents;
boolean
C0038317 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0021081 (UMLS CUI [2])
Life Expectancy
Item
life-expectancy less than 6 months;
boolean
C0023671 (UMLS CUI [1])
Age
Item
age less than 18 years old;
boolean
C0001779 (UMLS CUI [1])
Atrial Fibrillation | Relationship Pulse Wave Velocity
Item
atrial fibrillation (only for those undergoing the optional pulse wave velocity);
boolean
C0004238 (UMLS CUI [1])
C0439849 (UMLS CUI [2,1])
C3494431 (UMLS CUI [2,2])
Hypersensitivity Nitrates organic | Hypersensitivity Isosorbide | Hypersensitivity Nitroglycerin | Relationship Doppler blood flow measurement Brachial artery
Item
hypersensitivity to organic nitrates, isosorbide, or nitroglycerin (only for those undergoing the optional brachial artery doppler).
boolean
C0020517 (UMLS CUI [1,1])
C0028125 (UMLS CUI [1,2])
C0747055 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C0022251 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0017887 (UMLS CUI [3,2])
C0439849 (UMLS CUI [4,1])
C0599582 (UMLS CUI [4,2])
C0006087 (UMLS CUI [4,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial